Zobrazeno 1 - 4
of 4
pro vyhledávání: '"N. S. Beresneva"'
Publikováno v:
Российский офтальмологический журнал, Vol 15, Iss 4, Pp 7-17 (2022)
Purpose: to study long-term results of anti-VEGF therapy for macular diseases of patients followed up for 60 months in real clinical practice. Materials and methods. The research group included 57 patients (43 women, 14 men; median age 62 years) who
Externí odkaz:
https://doaj.org/article/131f58e76c6948a3a8dca17d7fbb1e01
Publikováno v:
Российский офтальмологический журнал, Vol 15, Iss 3, Pp 11-17 (2022)
Purpose: to study long-term (over a 60 months’ follow-up period) results of anti-VEGF therapy for macular diseases in real clinical practice.Materials and methods. We undertook a single-center retrospective uncontrolled cohort study of 169 patients
Externí odkaz:
https://doaj.org/article/07b1b56aead64fc0991a19b02e08bffd
Publikováno v:
Российский офтальмологический журнал, Vol 14, Iss 4, Pp 137-148 (2022)
Macular diseases are traditionally a serious issue in ophthalmology, which has great social impact due to widespread occurrence and significant vision loss, often irreversible. Over the past few decades, the possibilities for the diagnosis and treatm
Externí odkaz:
https://doaj.org/article/8a6f23d4b8db493dad88e3fae9c4544f
Publikováno v:
Vestnik oftalmologii. 137(2)
Patients lost to follow-up (LTFU) are a well-recognized challenge, both in clinical trials and in real clinical practice. PURPOSE: To study the reasons for patients receiving anti-VEGF therapy for «wet¼ age-related macular degeneration (wAMD) in cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4245785226cbcdb2bde5591641b0f81a
https://pubmed.ncbi.nlm.nih.gov/33881265
https://pubmed.ncbi.nlm.nih.gov/33881265